Efficacy of GLP-1 analog to achieve metabolic control and correction of body weight in patients with type 2 diabetes mellitus

Obesity associated with the enhanced risk of cardiovascular disorders plays a key role in the evolvement and progression of type 2 diabetes mellitus (DM2). Incretin mimetics are the sole class of hypoglycemic agents that not only effectively correct hyperglycemia but also reduce body weight. Exenati...

Celý popis

Podrobná bibliografie

Hlavní autoři:	T. V. Saprina, T. K. Gudkova, V. A. Stolyarova, S. Yu. Martynova, N. G. Dudarkova, T. G. Yaroshevskaya, Yu. A. Kabirova, O. A. Pavlenko, I. N. Vorozhtsova
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Siberian State Medical University (Tomsk) 2011-12-01
Edice:	Бюллетень сибирской медицины
Témata:	type 2 diabetes mellitus obesity incretin mimetics exenatide byetta
On-line přístup:	https://bulletin.ssmu.ru/jour/article/view/1511
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!